Xiao Fei Lan

Xiao Fei Lan

Auto-generated profile, based on publicly available information

Xiao Fei Lan

Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People's Republic of China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2014 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
HXHua Xu
Hua Xu
XLXiao Fei Lan
Xiao Fei Lan
QLQing Yun Li
Qing Yun Li
LZLi Na Zhou
Li Na Zhou
XZXiu Juan Zhang
Xiu Juan Zhang
BCBei Cao
Bei Cao

1 November 2019 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
YLYing Ni Lin
Ying Ni Lin
XLXiao Fei Lan
Xiao Fei Lan
ZLZhuo Ran Liu
Zhuo Ran Liu
YYYa Ru Yan
Ya Ru Yan
JZJian Ping Zhou
Jian Ping Zhou
QLQing Yun Li
Qing Yun Li
Purpose: Chronic intermittent hypoxia (CIH) contributes to the increased risk of cardiovascular diseases in obstructive sleep apnea (OSA). We previously reported the anti-apoptotic effects of estradiol (E2) on IH-exposed human umbilical vein endothelial cells (HUVECs). Herein, we employed a proteomic analysis to elucidate the mechanisms of the protective effects of E2 under IH exposure. Methods: HUVECs were divided into three groups: control, IH, and IH+E2 group. Isobaric tags for relative and absolute quantification (iTRAQ) were performed to compare protein profiles among the groups. Some of the identified proteins were validated by Western blotting. Results: A total of 185 proteins were differentially expressed in the IH+E2 group compared to the IH group. Bioinformatics analysis indicated that the effects of E2 may be linked to the regulation of cellular stress response. Among the differentially expressed proteins, we identified that serine-protein kinase ataxia telangiectasia mutated (ATM) and its downstream target, cellular inhibitor of apoptosis protein 1 (c-IAP1), were up-regulated by E2. We also observed that E2 decreased the level of cleaved caspase-3 and inhibited cell apoptosis in IH-exposed HUVECs. The inhibition of ATM abolished the anti-apoptotic effect of E2. Conclusion: The ATM-c-IAP1 pathway is involved in the cardioprotective effects of E2 in HUVECs exposed to IH.